Tag: European

EMA Panel Backs Peanut Allergy Desensitizing Powder Palforzia

The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) recommended on October 15 that marketing authorization be granted for Palforzia (Aimmune...

EMA OKs First CAR T-Cell Therapy for Mantle Cell Lymphoma

The European Medicines Agency (EMA) today recommended granting conditional marketing authorization to brexucabtagene autoleucel (Tecartus), making it the first approved chimeric antigen receptor (CAR) T-cell therapy for...

Oxford University Develops 5-Minute COVID Test

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Scientists at the Oxford University’s physics department have developed a COVID-19...

Flu Vaccine Significantly Cuts Pediatric Hospitalizations

Unlike previous studies focused on vaccine effectiveness (VE) in ambulatory care office visits, Angela P. Campbell, MD, MPH, and associates have uncovered evidence of the...

Surveillance After CRC Resection Does Not Improve Survival

Intensive surveillance with carcinoembryonic antigen (CEA) testing and CT scans after colorectal cancer resection did not improve recurrence-free or overall survival when compared with standard...

Delayed Cancer Screening Could Cause Increase in Deaths

Delays in colorectal cancer screening due to the COVID-19 pandemic could lead to higher rates of advanced-stage cancer and death, according to a new study....

Dexamethasone for Macular Edema Unresponsive to Anti-VEGF

When diabetic macular edema does not improve with anti-vascular endothelial growth-factor (VEGF) therapy, a quick and complete switch to dexamethasone might help, results from a...

Clinical Factors and Treatment Tied to COVID-19 Mortality

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Mortality in patients with COVID-19 and cancer is associated with general...

Pandemic Delays Treatment, Threatening Patients and Research

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The COVID-19 pandemic has taken a severe toll on patients with...

Success of AV Fistulas for Dialysis Varies Between Countries

The successful creation and use of arteriovenous fistulas (AVFs) for vascular access for dialysis patients varies considerably between countries, despite national guidelines that uniformly recommend...

Antibiotics or Appendectomy? Both Good Options

Patients given antibiotics for appendicitis fared no worse in quality of life, at least in the short term, than did patients whose appendix was removed,...

LSD Microdosing to Boost Attention: Too Soon to Tell?

Microdosing with lysergic acid diethylamide (LSD) is associated with improved mood and increased attention, early research suggests. However, at least one expert believes it’s far...

COVID-19 Risks No Higher in Patients With Multiple Sclerosis

The risk of severe outcomes from COVID-19 infection in patients with multiple sclerosis seems to align with that seen in the general population, new US...

PRAC Starts Safety Review of Remdesivir

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Reports of acute kidney injury in some patients with COVID-19 receiving...

New Drug for Prostate Cancer: Ipatasertib, an AKT Inhibitor

The investigational kinase inhibitor ipatasertib (Roche), which targets a key cancer metabolic pathway, has shown promise when used in combination with abiraterone (Zytiga) in the...

ECG Promising for Predicting Major Depression, Treatment Response

Individuals with major depressive disorder (MDD) have an increased heart rate — a finding that may have the potential to identify individuals at risk for...

‘Startling’ Decline in BP Control Among American Adults

After years of improvement, the number of Americans whose blood pressure (BP) is under control is declining, suggest two new analyses of data from the...

‘About 40%-45% of Infections Are Asymptomatic’

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Anthony Fauci, MD, highlighting the latest COVID-19 developments on Friday, said,...

Sudden Death Not So Sudden? Half Contacted GP in Days Prior

People who experience “sudden” out-of-hospital cardiac arrest (OHCA) may feel malaise days earlier, new research from Denmark suggests. The new analysis shows that 2 weeks...

The Earlier the Better for Colchicine Post-MI: COLCOT

The earlier the anti-inflammatory drug colchicine is initiated after a myocardial infarction (MI) the greater the benefit, a new COLCOT analysis suggests. The parent trial...

Many Advanced Countries Missing Targets for HCV Elimination

Eleven high-income countries are on track to meet World Health Organization targets to eliminate hepatitis C infection by 2030, compared with nine countries 2 years...

New ESC/EACTS Guideline on Atrial Fibrillation

New atrial fibrillation management guidelines from the European Society of Cardiology (ESC) call for diagnostic confirmation and structured characterization of AF and the need to...

RATE-AF Trial Boosts Digoxin for Rate Control in Permanent AF

Digoxin now deserves to be considered first-line therapy for long-term heart rate control in older patients with permanent atrial fibrillation and symptoms of heart failure,...

Early Rhythm Control in AF Gains New Life

Initiation of rhythm control with antiarrhythmic drugs and/or ablation in patients with early, recently diagnosed atrial fibrillation led to a significantly lower risk for major...

Empagliflozin’s HFrEF Benefit Solidifies Class Effects

The SGLT2 inhibitor drug class solidified its role as a major, new treatment for patients who have heart failure with reduced ejection fraction and no...